Trastuzumab increased the radiosensitivity of HER-2-overexpressing MCF7 breast cancer cells as measured by in vitro colony-forming assays, and the combination of trastuzumab and radiation showed synergistic tumour reduction in nude mice (Pietras et al, 1999). This evidence concerns the gene ERBB2 and breast cancer.